Allylescaline

Allylescaline
Chemical Nomenclature
Common names	Allylescaline, AL
Substitutive name	4-allyloxy-3,5-dimethoxyphenethylamine
Systematic name	4-Allyloxy-3,5-dimethoxyphenethylamine
Class Membership
Psychoactive class	Psychedelic
Chemical class	Phenethylamine
Routes of Administration
Oral Dosage WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. Threshold 15 - 20 mg Light 20 - 30 mg Common 30 - 40 mg Strong 40 - 60 mg Heavy 60 mg + Duration Total 8 - 12 hours Onset 45 - 240 minutes

Allylescaline, AL or 4-allyloxy-3,5-dimethoxyphenethylamine is a psychedelic drug and entheogen of the phenethylamine class of compounds. It is relatively uncommon and has little to no history of human usage. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline.

The effects of this compound were first described by Alexander Shulgin in his book PiHKAL: A Chemical Love Story. He lists the dosage range as 20 – 35 mg orally and describes the duration of action to be 8 - 12 hours.^[1]

Allylescaline acts as a 5-HT_2A partial agonist. The psychedelic effects are believed to come from allylescaline's efficacy at the 5-HT_2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

This subjective effect breakdown is a stub. As such, it may contain incomplete or wrong information and is still in progress. You can help by expanding it.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects

• Spontaneous tactile sensations
• Stimulation
• Nausea
• Tactile enhancement
• Bodily control enhancement
• Pupil dilation
• Wakefulness
• Physical euphoria

Cognitive effects

• Emotion enhancement
• Thought acceleration
• Novelty enhancement
• Time distortion
• Analysis enhancement
• Personal bias suppression
• Conceptual thinking
• Immersion enhancement
• Memory suppression
• Thought loops
• Thought disorganization
• Unity and interconnectedness

Visual effects

Enhancements

• Acuity enhancement
• Colour enhancement
• Pattern recognition enhancement

Distortions

• Drifting (melting, flowing, breathing and morphing)
• Tracers
• After images
• Symmetrical texture repetition
• Colour shifting

Geometry

Hallucinatory states

• Transformations

Auditory effects

• Enhancements
• Distortions
• Hallucinations

Main articles: Research chemicals § Toxicity and harm potential & Responsible use § Hallucinogens

The toxicity and long-term health effects of recreational allylescaline use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because allylescaline is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried allylescaline suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

Allylescaline is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.

Tolerance to the effects of allylescaline are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). Allylescaline presents cross-tolerance with all psychedelics, meaning that after the consumption of allylescaline all psychedelics will have a reduced effect.

This legality section is a stub. As such, it likely contains incomplete or wrong information. You can help by expanding it.

• United Kingdom - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.^[2]

• Responsible use
• Mescaline
• Phenethylamine
• Hallucinogen

• Allylescaline (PiHKAL)
• Allylescaline (Wikipedia)
• Allylescaline experiences (Erowid)
• Allylescaline (Tripsit)

1. ↑ https://www.erowid.org/library/books_online/pihkal/pihkal002.shtml | Allylescaline (TiHKAL)
2. ↑ Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted